Breast Health

June 28, 2022

Gynecologists and physicians, in concert with mothers, are key not only to a woman’s early awareness of both breast cancer and mammography but to awareness of breast cancer risk factors as well.

November 08, 2021

A recently published study evaluated nearly 30,000 patients and found about 5% of Black and White women have the same genetic mutations that are associated with an increased risk of breast cancer.

November 05, 2021

A recent study suggests that unconscious or implicit bias may exist when it comes to physicians referring African American patients with breast cancer for genetic counseling and testing.

July 08, 2020

New research shows that, in postmenopausal women undergoing hormone therapy for breast cancer, aromatase inhibitors (AIs) lead to a reduction in climacteric symptoms and significantly improved quality of life.

June 23, 2020

Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.

June 12, 2020

Findings from a new study show significant overall survival benefit of Novartis’ ribociclib in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer with visceral metastases.

June 04, 2020

Long-term adherence improvements, it appears, require personalized and sustained behavioral interventions. TMs for AI should also be personalized for individual success.

October 29, 2019

The agency issued the guidance in response to concerns that some women are not receiving and/or understanding information about the risks and benefits of the devices.

October 03, 2019

Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration. 

February 20, 2019

A recent study aimed to quantify the effectiveness of improvements in screening and treatment.